Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Opti-Free is a brand of multi-purpose disinfecting solutions for soft contact lenses manufactured by Alcon Laboratories. The product line includes Opti-Free PureMoist and Opti-Free Replenish. **Opti-Free PureMoist** is a multi-purpose solution containing a proprietary HydraGlyde Moisture Matrix technology. It is used to clean, disinfect, rinse, store, and recondition soft contact lenses, including silicone hydrogel lenses. Key ingredients include Sodium citrate, Sodium chloride, Boric acid, Sorbitol, Aminomethylpropanol, Disodium EDTA, and wetting agents like TETRONIC 1304 and HydraGlyde Moisture Matrix (EOBO-41-polyoxyethylene-polyoxybutylene). It contains preservatives POLYQUAD (polyquaternium-1) 0.001% and ALDOX (myristamidopropyl dimethylamine) 0.0006%. **Opti-Free Replenish** is another solution in the line featuring the TearGlyde reconditioning system instead of HydraGlyde, serving similar contact lens care purposes. Both products offer: * **Disinfection**: Utilizing POLYQUAD and ALDOX to kill 99.9% of germs. * **Moisture/Comfort**: PureMoist uses HydraGlyde for hydration; Replenish uses TearGlyde. * **Cleaning**: Removes protein and reduces lipid deposits. * **Compatibility**: Suitable for silicone hydrogel and soft (hydrophilic) lenses. * **Storage**: Allows lens storage for up to 30 days after disinfection. The recommended use involves a 5-step cleaning, rinsing, and storing process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Opti-Free.